Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | DNLI | MRUS | ||
| Company | Dicerna Pharmaceutic | Denali Therapeutics Inc | Merus N.V. CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.21 | 21.10 | 43.63 | ||
| High | 38.24 | 21.39 | 43.86 | ||
| Low | 38.21 | 19.73 | 42.32 | ||
| Last | 38.22 | 19.82 | 42.39 | ||
| Change | +0.22 | -1.44 | -0.77 | ||
| % Change | +0.58% | -6.77% | -1.78% | ||
| Volume | 5,568,900 | 1,621,200 | 270,400 | ||
| 20-Day Average Volume | 3,647,665 | 932,830 | 581,610 | ||
| Previous Close | 38.00 | 21.26 | 43.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 22.08 | 42.74 | ||
| 20-Day Raw Stochastic | 90.72% | 1.40% | 28.33% | ||
| 20-Day Relative Strength | 80.40% | 34.41% | 43.03% | ||
| Weighted Alpha | +35.17 | -7.80 | -1.61 | ||
| Today's Opinion | 88% Buy | 56% Sell | 100% Sell | ||
| Previous Opinion | 72% Buy | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 24% Buy | 8% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | -3.83% since 12/27/24 | +0.76% since 12/27/24 | ||
| Low | 37.81 on 12/21/21 | 19.73 on 01/06/25 | 41.23 on 12/31/24 | ||
| High | 38.24 on 12/27/21 | 21.56 on 01/03/25 | 43.86 on 01/06/25 | ||
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | -20.37% since 12/06/24 | -5.06% since 12/06/24 | ||
| Low | 37.78 on 12/10/21 | 19.73 on 01/06/25 | 41.03 on 12/13/24 | ||
| High | 38.26 on 12/03/21 | 26.18 on 12/09/24 | 45.83 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | -30.77% since 10/04/24 | -18.13% since 10/04/24 | ||
| Low | 19.06 on 10/06/21 | 19.73 on 01/06/25 | 41.03 on 12/13/24 | ||
| High | 38.26 on 12/03/21 | 33.33 on 11/11/24 | 55.39 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | -6.24% since 07/05/24 | -20.53% since 07/05/24 | ||
| Low | 19.06 on 10/06/21 | 19.73 on 01/06/25 | 41.03 on 12/13/24 | ||
| High | 40.14 on 07/20/21 | 33.33 on 11/11/24 | 59.38 on 07/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 3,059,782 | 2,954,906 | ||
| Shares Outstanding, K | 78,129 | 143,922 | 68,464 | ||
| Annual Sales | 164,310,000 | 330,530,000 | 43,950,000 | ||
| Annual Net Income | -112,750,000 | -145,220,000 | -154,940,000 | ||
| Last Quarter Sales | 62,950,000 | 0 | 11,770,000 | ||
| Last Quarter Net Income | -17,070,000 | -107,190,000 | -99,910,000 | ||
| 60-Month Beta | 0.80 | 1.39 | 1.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | -0.63 on 11/06/24 | -0.95 on 10/31/24 | ||
| Latest Earnings Date | 11/09/21 | 02/25/25 | 02/26/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||